These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 12422595)

  • 41. A comprehensive clinical and laboratory evaluation of 224 patients with persistent symptoms attributed to presumed tick-bite exposure.
    Nilsson K; Skoog E; Jones V; Labbé Sandelin L; Björling C; Fridenström E; Edvinsson M; Mårtensson A; Olsen B
    PLoS One; 2021; 16(3):e0247384. PubMed ID: 33735220
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Skin manifestations of Lyme borreliosis].
    Nammous AH; Zubacki D; Dobrzycki I
    Przegl Lek; 2006; 63(4):227-30. PubMed ID: 17080746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Lyme disease (borreliosis)].
    Savchak VI; Andreĭchyn IuM
    Lik Sprava; 1998 Aug; (6):134-6. PubMed ID: 9844899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005].
    Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA
    Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lyme borreliosis.
    Scarpa C; Trevisan G; Stinco G
    Dermatol Clin; 1994 Oct; 12(4):669-85. PubMed ID: 7805296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dermatological aspects of Lyme borreliosis].
    Lipsker D
    Med Mal Infect; 2007; 37(7-8):540-7. PubMed ID: 17391884
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cutaneous manifestations of Lyme borreliosis.
    Aberer E; Klade H
    Infection; 1991; 19(4):284-6. PubMed ID: 1917047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development of erythema migrans in spite of treatment with antibiotics after a tick bite.
    Maraspin V; Lotric-Furlan S; Strle F
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):616-9. PubMed ID: 12422612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential expression of cytokine mRNA in skin specimens from patients with erythema migrans or acrodermatitis chronica atrophicans.
    Müllegger RR; McHugh G; Ruthazer R; Binder B; Kerl H; Steere AC
    J Invest Dermatol; 2000 Dec; 115(6):1115-23. PubMed ID: 11121150
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lyme borreliosis: aspects of tick-borne Borrelia burgdorferi infection from a dermatologic viewpoint.
    Asbrink E; Hovmark A
    Semin Dermatol; 1990 Dec; 9(4):277-91. PubMed ID: 2285572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Early diagnosis of Lyme borreliosis. Do not look only for erythema migrans].
    Hofmann H
    MMW Fortschr Med; 2002 May; 144(22):24-8. PubMed ID: 12116567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Lyme borreliosis--experience of the last 25 years in Hungary].
    Lakos A
    Orv Hetil; 2009 Apr; 150(16):725-32. PubMed ID: 19362925
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma.
    Müllegger RR; Means TK; Shin JJ; Lee M; Jones KL; Glickstein LJ; Luster AD; Steere AC
    Infect Immun; 2007 Sep; 75(9):4621-8. PubMed ID: 17606602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Lyme borreliosis: underdiagnosed?--overtreated?].
    Peuckert W
    Monatsschr Kinderheilkd; 1990 Apr; 138(4):190-5. PubMed ID: 2192269
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Lyme borreliosis. Cutaneous manifestation].
    Hofmann H
    Hautarzt; 2005 Aug; 56(8):783-95; quiz 796. PubMed ID: 16025277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An Enzyme-Linked Immunosorbent Spot Assay Measuring Borrelia burgdorferi B31-Specific Interferon Gamma-Secreting T Cells Cannot Discriminate Active Lyme Neuroborreliosis from Past Lyme Borreliosis: a Prospective Study in the Netherlands.
    van Gorkom T; Sankatsing SUC; Voet W; Ismail DM; Muilwijk RH; Salomons M; Vlaminckx BJM; Bossink AWJ; Notermans DW; Bouwman JJM; Kremer K; Thijsen SFT
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29367297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term prognosis in patients treated for erythema chronicum migrans and acrodermatitis chronica atrophicans.
    Hulshof MM; Vandenbroucke JP; Nohlmans LM; Spanjaard L; Bavinck JN; Dijkmans BA
    Arch Dermatol; 1997 Jan; 133(1):33-7. PubMed ID: 9006370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Serodiagnosis of Lyme borreliosis: antibody titer and specificity in the IFT and western blot].
    Grellner W; Erbguth F; Brade V
    Immun Infekt; 1989 Dec; 17(6):189-94. PubMed ID: 2693341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.